10-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1157 19 991 85 1035 178 1084
ERLYTX 88 3 157 8 97 17 103
GI 171 2 104 15 183 32 195
GU 349 9 470 43 524 75 457
LEUK 160 5 261 22 268 39 237
LUNG 206 3 157 19 231 37 225
LYMPH 420 8 417 37 450 82 499
MELAN 70 0 0 0 0 0 0
MMYEL 118 2 104 9 110 24 146
MULT 47 2 104 5 61 9 55
OTHER 55 1 52 5 61 7 43
SXQOL 3 1 52 3 37 3 18
Total 2844 55 2869 251 3057 503 3062

10-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
CCD 178 8 417 25 304 40 244
ERLYTX 5 0 0 1 12 1 6
GU 4 0 0 0 0 1 6
LEUK 617 7 365 41 499 93 566
LUNG 381 6 313 25 304 55 335
OTHER 12 0 0 1 12 2 12
PEOLC 100 1 52 3 37 6 37
PREV 251 2 104 26 317 49 298
SXQOL 632 10 522 37 450 93 566
Total 2181 35 1825 160 1947 341 2076

10-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
BREAST 1157 19 991 85 1035 178 1084
CCD 178 8 417 25 304 40 244
ERLYTX 93 3 157 9 110 18 110
GI 171 2 104 15 183 32 195
GU 353 9 470 43 524 76 463
LEUK 777 12 626 63 767 132 804
LUNG 587 9 470 44 536 92 560
LYMPH 420 8 417 37 450 82 499
MELAN 70 0 0 0 0 0 0
MMYEL 118 2 104 9 110 24 146
MULT 47 2 104 5 61 9 55
OTHER 67 1 52 6 73 9 55
PEOLC 100 1 52 3 37 6 37
PREV 251 2 104 26 317 49 298
SXQOL 635 11 574 40 487 96 584
Total 5025 90 4694 411 5006 844 5140

10-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 718 11 574 51 621 104 633
ERLYTX 54 3 157 5 61 12 73
GI 126 1 52 11 134 21 128
GU 269 5 261 30 365 54 329
LEUK 100 4 209 14 170 24 146
LUNG 127 0 0 8 97 22 134
LYMPH 274 3 157 22 268 54 329
MELAN 48 0 0 0 0 0 0
MMYEL 68 1 52 4 49 11 67
MULT 18 1 52 2 24 4 24
OTHER 54 0 0 4 49 6 37
SXQOL 2 0 0 2 24 2 12
Total 1858 29 1514 153 1862 314 1912

10-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 137 6 313 17 207 27 164
ERLYTX 5 0 0 1 12 1 6
GU 4 0 0 0 0 1 6
LEUK 268 5 261 17 207 42 256
LUNG 232 3 157 15 183 33 201
OTHER 12 0 0 1 12 2 12
PEOLC 76 1 52 3 37 6 37
PREV 251 2 104 26 317 49 298
SXQOL 459 7 365 24 292 62 377
Total 1444 24 1252 104 1267 223 1357

10-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 894 15 783 63 767 130 791
CCD 160 1 52 13 158 22 134
ERLYTX 59 3 157 6 73 13 79
GI 131 0 0 13 158 22 134
GU 303 7 365 29 353 58 353
LEUK 369 9 470 31 377 66 402
LUNG 381 5 261 26 317 58 353
LYMPH 274 3 157 22 268 54 329
MELAN 48 0 0 0 0 0 0
MMYEL 68 1 52 4 49 11 67
MULT 42 1 52 1 12 7 43
OTHER 167 0 0 5 61 8 49
PEOLC 74 3 157 5 61 8 49
PREV 251 2 104 26 317 49 298
SXQOL 461 7 365 26 317 64 390
Total 3682 57 2975 270 3288 570 3471

10-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 974 17 887 76 925 160 974
ERLYTX 83 3 157 8 97 17 103
GI 101 0 0 9 110 21 128
GU 245 6 313 31 377 56 341
LEUK 127 5 261 19 231 35 213
LUNG 177 3 157 18 219 34 207
LYMPH 352 8 417 29 353 69 420
MMYEL 105 2 104 9 110 21 128
MULT 47 2 104 5 61 9 55
Total 2211 46 2400 204 2483 422 2569

10-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1945 27 1409 147 1790 312 1899
AFFIL 142 0 0 8 97 24 146
CCOP/NCORP 1215 26 1357 102 1242 201 1224
Non-SWOG 1719 33 1722 150 1826 303 1845
Total 5021 86 4488 407 4955 840 5114

10-JUL-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
ERLYTX S2505 Sarcoma, Stg II-IIIB, Surg + Short vs Std RT 1 Y 06-JUL-26

10-JUL-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
BREAST MA39 BREAST, Node-Pos, Reg RT vs No Reg RT 1 E 30-JUN-26
BREAST MA39 BREAST, Node-Pos, Reg RT vs No Reg RT 2 E 30-JUN-26
OTHER NRGBN013 Brain, Intact Metas, SRS vs FSRS 1 E 22-JUN-26
ERLYTX S2012 Extrapulm NEC, Stg IV, Combo Chemo +/- Atezo 1 T 09-JUL-26

10-JUL-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 14
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 9
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 8
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 7
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 7
LUNG LUNGMAP NSCLC, Adv, Master 2 6
LUNG LUNGMAP NSCLC, Adv, Master 1 6
CCD S1703 Met Breast, STM-monitoring v Usual Care 2 5
MMYEL S1803 MM, Maintenance, Len vs Len/Dara 3 5
LUNG S2409 ESCLC, Durvalumab +/- Biomarker Directed Tx 1 4
CCD EAQ222CD CostCOM, Cancer Patients, OOP Cost Com 0 3
PEOLC S1501 Surv, Breast Stg IV, Card Tox w/ Carvedilol 1 3
LEUK S1925 CLL/SLL, Newly Dx HR, Early vs Delayed V+O 1 3
ERLYTX S2012 Extrapulm NEC, Stg IV, Combo Chemo +/- Atezo 1 3
MULT S2101 Melan or HNSCC, Adv, Cabo + Nivo 1 3
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 3
CCD S2417CD Colrec Surv, Follow-up w/ CTAC site 1 3
GU S2427 Blad, MIBC, RT + Pembrolizumab 1 3